GXO Logistics (GXO) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Achieved record revenue of $11.7 billion and adjusted EBITDA of $815 million in 2024, with organic revenue growth of 3% and strong expansion into new verticals and geographies.
CEO transition planned for 2025, with Malcolm Wilson retiring and a new CEO to be appointed; five new directors nominated to refresh the Board.
Continued investments in automation and AI, enhancing competitive advantages and operational efficiency.
Maintained a global workforce of over 150,000 and managed 1,071 facilities worldwide.
Voting matters and shareholder proposals
Shareholders will vote on: (1) election of nine directors for one-year terms, (2) ratification of KPMG LLP as independent auditor for 2025, and (3) advisory approval of executive compensation (say-on-pay).
Board recommends voting FOR all director nominees, FOR auditor ratification, and FOR executive compensation approval.
Majority voting standard applies for director elections; directors not receiving a majority must tender resignation.
Board of directors and corporate governance
Board comprises nine members, with five new nominees bringing expertise in supply chain, finance, and technology.
Eight of nine directors are independent; all standing committees are fully independent.
Board leadership includes a non-executive chairman, lead independent director, and (until the 2025 meeting) a vice chair.
Board refreshment and annual evaluations ensure alignment with strategy and diversity of perspectives.
Four standing committees: Audit, Compensation, Nominating/Corporate Governance/Sustainability, and new Operational Excellence Committee.
Latest events from GXO Logistics
- Record revenue and new business wins drive strong 2026 outlook and margin expansion.GXO
Q4 202511 Feb 2026 - Q2 revenue up 19% to $2.85B, but net income down 41% amid acquisition and litigation costs.GXO
Q2 20242 Feb 2026 - Q3 revenue up 28% to $3.2B, strong pipeline, but net income down on higher costs.GXO
Q3 202416 Jan 2026 - Record 2024 results and strong 2025 outlook with margin expansion and robust pipeline.GXO
Q4 202415 Dec 2025 - Q2 2025 revenue up 16%, guidance raised, Wincanton deal approved, CEO transition underway.GXO
Q2 202523 Nov 2025 - Q1 revenue up 21% to $3B, net loss $95M, guidance reaffirmed, and NHS contract boosts outlook.GXO
Q1 202519 Nov 2025 - Record Q3 revenue, 71% net income growth, and robust pipeline drive strong outlook.GXO
Q3 202513 Nov 2025